New graft aims to keep dialysis patients connected longer
NCT ID NCT05729620
First seen Apr 28, 2026 · Last updated May 22, 2026 · Updated 5 times
Summary
This study tests a new type of blood vessel graft (STARgraft-3) for people with end-stage kidney disease who need dialysis. The graft is designed to resist common problems like narrowing and infection. About 21 participants will be followed for up to a year to see how well the graft stays open and working.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Italian Hospital
Asunción, Paraguay
Conditions
Explore the condition pages connected to this study.